News
-
-
-
-
PRESS RELEASE
Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R)
Radius Pharmaceuticals and Ipsen Pharma win patent infringement suit against Orbicular Pharmaceutical Technologies for TYMLOS® generic for osteoporosis, upholding five patents validity until 2038 -
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Correction of a release from 31/07/2025, 18:25 CET/CEST - CANCOM SE publishes preliminary figures for the first half of 2025 and adjusts its forecast for the 2025 financial year
CANCOM SE adjusts forecast for 2025 financial year due to customer reluctancy, with revenue of €803.8 million for H1 2025. Market challenges impacting business -
PRESS RELEASE
Publication of the 2025 Annual Accounts and Financial Report
AVENTADOR announces the publication of its 2025 Annual Accounts and Financial Report, revealing restructuring milestones. New management, shareholding changes, cost-cutting measures, and ongoing receivership for business continuity